Followers | 104 |
Posts | 2500 |
Boards Moderated | 0 |
Alias Born | 12/02/2016 |
Thursday, September 21, 2017 4:13:26 PM
What I've understood after listening to last week's Parliament hearing, is that South Africa has gone through much of the due process, and is consequently now positioned to reschedule/down-schedule cannabis within the next few weeks.
https://drive.google.com/file/d/0B4WJojoiFSszTVE5UERWdFAxWmc/view
Upon the SA governmental ratification, according to the founder of SACCRA Jason Sean O'Donoghue, Plandai SA/Protext Pharma is expected to "gain access" to a research and development license that will allow for the company to employ its proprietary technology to produce a pharmaceutical grade non-psychoactive cannabis product under license from America. IMO, the implications of South Africa down-scheduling cannabis are profound for $TXTM. It will be interesting to see what unfolds over the next few weeks.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM